Acta Vet. Brno 2025, 94: 231-242
https://doi.org/10.2754/avb202594030231
Therapeutic use meets environmental concern: Gabapentin’s toxicological profile in aquatic ecosystems – a review
References
1. BW 2019: Update on antiepileptic drugs 2019: Continuum (Minneap Minn) 25: 508-536
<https://doi.org/10.1212/CON.0000000000000715>
2. CS, Tran-van-Minh A, Kadurin I, Dolphin AC 2010: A new look at calcium channel α2δ subunits. Curr Opin Neurobiol 20: 563-571
<https://doi.org/10.1016/j.conb.2010.05.007>
3. M 2006: New antiepileptic drugs that are second-generation to existing antiepileptic drugs. Expert Opin Investig Drugs 15: 637-647
<https://doi.org/10.1517/13543784.15.6.637>
4. J, Mikula P, Marsalek P, Svobodova Z 2025: Biochemical and antioxidant responses of common carp (Cyprinus carpio) exposed to sublethal concentrations of the antiepileptic and analgesic drug gabapentin. Vet Med 70: 20-29
<https://doi.org/10.17221/75/2024-VETMED>
5. S, Medam T, Masson S 2021: Effects of a single oral dose of gabapentin on storm phobia in dogs: A double-blind, placebo-controlled crossover trial. Vet Rec 189: e453
<https://doi.org/10.1002/vetr.453>
6. K, Machin J, Maylin G, Fenger C, Morales-Briceńo A, Tobin T 2022: Gabapentin, a human therapeutic medication an environmental substance transferring at trace levels to horses: a case report. Ir Vet J 75: 19
<https://doi.org/10.1186/s13620-022-00226-5>
7. MJ, Dichter MA 1997: Established antiepileptic drugs. Seizure 6: 159-174
<https://doi.org/10.1016/S1059-1311(97)80001-5>
8. AYL, Yuen ASC, Tsai DHT et al. 2023: Gabapentinoid consumption in 65 countries and regions from 2008 to 2018: a longitudinal trend study. Nat Commun 14: 5005
<https://doi.org/10.1038/s41467-023-40637-8>
9. M, Villarroel-Hagemann S, Mendoza-Rodelo I, Palacios-Sánchez L, Gaviria-Carrillo M, Buitrago-Ricaurte N, Espinosa-Lugo S, Calderon-Ospina CA, Rodríguez-Quintana JH 2023: Development of antiepileptic drugs throughout history: From serendipity to artificial intelligence. Biomedicines 11: 1632
<https://doi.org/10.3390/biomedicines11061632>
10. F, Medina C, Zorzi M, Kuck B, Fabri D, Calza P 2020: Liquid chromatography/mass spectrometry analytical determination of gabapentin transformation products by heterogeneous photocatalysis and environmental evaluation. Rapid Commun Mass Spectrom 34: e8925
<https://doi.org/10.1002/rcm.8925>
11. JA 1995: Mechanisms of action of antiepileptic drugs. Seizure 4: 267-271
<https://doi.org/10.1016/S1059-1311(95)80003-4>
12. JL, Posner LP, Elce Y 2007: Gabapentin for the treatment of neuropathic pain in a pregnant horse. J Am Vet Med Assoc 231: 755-758
<https://doi.org/10.2460/javma.231.5.755>
13. F, Negro V, Ravasio G, Villa R, Draghi S, Cagnardi P 2023: Gabapentin: clinical use and pharmacokinetics in dogs, cats, and horses. Animals (Basel) 13: 2045
<https://doi.org/10.3390/ani13122045>
14. JS 2002: The promise of new antiepileptic drugs. Br J Clin Pharmacol 53: 123-131
<https://doi.org/10.1046/j.0306-5251.2001.01540.x>
15. Ç, Allen NJ, Susman MW, O’Rourke NA, Park CY, Ozkan E, Chakraborty C, Mulinyawe SB, Annis DS, Huberman AD, Green EM, Lawler J, Dolmetsch R, Garcia KC, Smith SJ, Luo ZD, Rosenthal A, Mosher DF, Barres BA 2009: Gabapentin receptor α2δ-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell 139: 380-392
<https://doi.org/10.1016/j.cell.2009.09.025>
16. M, Blahova J, Schovankova J, Siroka Z, Svobodova Z, Kodes V, Stepankova K, Lakdawala P 2022: Residues of selected anticonvulsive drugs in surface waters of the Elbe River Basin (Czech Republic). Water (Basel) 14: 4122
17. Gallimore C, Gidal B 2010: Gabapentin. In: Panayiotopoulos CP (Ed.): Atlas of Epilepsies. Springer, London, pp. 1753-1760
18. I, Flatters S 2006: Gabapentin and pregabalin for the treatment of neuropathic pain: A review of laboratory and clinical evidence. Pain Res Manag 11: 16A-29A
<https://doi.org/10.1155/2006/651712>
19. A, Jiang JQ, Petri M 2019: Non-parametric regression analysis of diuron and gabapentin degradation in Lake Constance water by ozonation and their toxicity assessment. Water (Basel) 11: 852
20. M, Perkins M, Malik R 2005: Improving seizure control in dogs with refractory epilepsy using gabapentin as an adjunctive agent. Aust Vet J 83: 602-608
<https://doi.org/10.1111/j.1751-0813.2005.tb13269.x>
21. R, Rössler M, Marx C, Diamond S, Schubert S, Oertel R, Fauler J 2015: Occurrence and removal of frequently prescribed pharmaceuticals and corresponding metabolites in wastewater of a sewage treatment plant. Sci Total Environ 532: 762-770
<https://doi.org/10.1016/j.scitotenv.2015.06.067>
22. Y, Hu J, Freitas R, Gu J, Ji G, Zhang Y 2024: Trace-level gabapentin can induce cardiovascular developmental toxicity through apoptosis in zebrafish larvae. Environ Pollut 358: 124526
<https://doi.org/10.1016/j.envpol.2024.124526>
23. Y, Li X, Jia D, Zhang W, Zhang T, Yu Y, Xu Y, Zhang Y 2019: A transcriptomics-based analysis of the toxicity mechanisms of gabapentin to zebrafish embryos at realistic environmental concentrations. Environ Pollut 251: 746-755
<https://doi.org/10.1016/j.envpol.2019.05.063>
24. Y, Li X, Yang Y, Freitas R, Zhu J, Ji G, Zhang Y 2025a: Gabapentin impairs visual development in zebrafish via retinal apoptosis and thyroid disruption. J Hazard Mater 487: 137299
<https://doi.org/10.1016/j.jhazmat.2025.137299>
25. Y, Wang C, Sun Q, Liu R, Wang C, Zhou R, Freitas R, Zhang Y 2025b: Are environmental levels of gabapentin (GBP) a cause for concern? Chronic reproductive effects of GBP in zebrafish. J Hazard Mater 492: 138173
<https://doi.org/10.1016/j.jhazmat.2025.138173>
26. J, Bai Y, Kreuder F, Saaristo M, Kaslin J, Wlodkowic D 2022: Sensory-motor perturbations in larval zebrafish (Danio rerio) induced by exposure to low levels of neuroactive micropollutants during development. Int J Mol Sci 23: 8990
<https://doi.org/10.3390/ijms23168990>
27. M, Menz J, Olsson O, Kümmerer K 2015: Identification of phototransformation products of the antiepileptic drug gabapentin: Biodegradability and initial assessment of toxicity. Water Res 85: 11-21
<https://doi.org/10.1016/j.watres.2015.08.004>
28. E, Schmitz B, Carreño M 2003: Epilepsy, antiepileptic drugs (AEDs) and cognition. Acta Neurol Scand 108: 23-32
<https://doi.org/10.1034/j.1600-0404.108.s180.4.x>
29. CP, Griffin CE 2020: Changes in the stress markers cortisol and glucose before and during intradermal testing in cats after a single administration of pre-appointment gabapentin. J Feline Med Surg 22: 138-145
<https://doi.org/10.1177/1098612X19830501>
30. B, Dinsdale RM, Guwy AJ 2008: The occurrence of pharmaceuticals, personal care products, endocrine disruptors, and illicit drugs in surface water in South Wales, UK. Water Res 42: 3498-3518
<https://doi.org/10.1016/j.watres.2008.04.026>
31. B, Dinsdale RM, Guwy AJ 2009: The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Res 43: 363-380
<https://doi.org/10.1016/j.watres.2008.10.047>
32. K, Endoh F, Ohmori I, Akiyama T 2020: Action of antiepileptic drugs on neurons. Brain Dev 42: 2-5
<https://doi.org/10.1016/j.braindev.2019.07.006>
33. JW, Dworetzky B 2010: Rational polytherapy with antiepileptic drugs. Pharmaceuticals 3: 2362-2379
<https://doi.org/10.3390/ph3082362>
34. X, Zhou S, Qian Y, Xu Z, Yu Y, Xu Y, He Y, Zhang Y 2018: The assessment of the eco-toxicological effect of gabapentin on early development of zebrafish and its antioxidant system. RSC Adv 8: 22777-22784
<https://doi.org/10.1039/C8RA04250K>
35. RL, Kelly KM 1995: Antiepileptic drug mechanisms of action. Epilepsia 36: S2-S12
<https://doi.org/10.1111/j.1528-1157.1995.tb05996.x>
36. L 1999: Nonepileptic uses of gabapentin. Epilepsia 40: S66-S72
<https://doi.org/10.1111/j.1528-1157.1999.tb00936.x>
37. J, Chen LL 2000: Gabapentin in pain management. Anesth Analg 91: 680-687
<https://doi.org/10.1213/00000539-200009000-00034>
38. E, Klugbauer N, Hofmann F 2001: Calcium channel α2δ subunits—structure and gabapentin binding. Mol Pharmacol 59: 1243-1248
<https://doi.org/10.1124/mol.59.5.1243>
39. J, Kienle C, Magnet A, Weil M, Rossi L, De Alencastro LF, Abegglen C, Thonney D, Chèvre N, Schärer M, Barry D 2013: Treatment of micropollutants in municipal wastewater: Ozone or powdered activated carbon? Sci Total Environ 461-462: 480-498
<https://doi.org/10.1016/j.scitotenv.2013.05.034>
40. J, Lochmatter S, Barry DA, Holliger CH 2016: Role of ammonia-oxidizing bacteria in micropollutant removal from wastewater with aerobic granular sludge. Water Sci Technol 73: 564-575
<https://doi.org/10.2166/wst.2015.514>
41. NT, Rapoport A, Saper J, Magnus L, Klapper J, Ramadan N, Stacey B, Tepper S 2001: Efficacy of gabapentin in migraine prophylaxis. Headache 41: 119-128
<https://doi.org/10.1046/j.1526-4610.2001.111006119.x>
42. MJ 1994: Clinical pharmacokinetics of gabapentin. Neurology 44: 17-22
43. MJ 1995: Gabapentin. Epilepsia 36: S73-S86
<https://doi.org/10.1111/j.1528-1157.1995.tb06001.x>
44. T, Robinson J, Rose J, Vernick J, Overall KL 2021: Development of and pharmacological treatment options and future research opportunities for separation anxiety in dogs. J Am Vet Med Assoc 259: 1130-1139
<https://doi.org/10.2460/javma.20.10.0602>
45. GL 1999: Gabapentin. Epilepsia 40: S63-S70
<https://doi.org/10.1111/j.1528-1157.1999.tb00921.x>
46. KO, Brodtkorb E 2020: Are the new anti-epileptic drugs any better than their predecessors? Tidsskr Nor Laegeforen 140: 1-7
47. National Center for Biotechnology Information (NCBI) 2024: PubChem Compound Summary for CID 3446, Gabapentin. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/Gabapentin. Accessed March 5, 2025
48. B 2000: Gabapentin use in neuropathic pain syndromes. Acta Neurol Scand 101: 359-371
<https://doi.org/10.1034/j.1600-0404.2000.0006a.x>
49. K, Virgiliou CH, Theodoridis G, Gika H, Grintzalis K 2023a: The impact of pharmaceutical pollutants on daphnids – A metabolomic approach. Environ Toxicol Pharmacol 100: 104157
<https://doi.org/10.1016/j.etap.2023.104157>
50. K, Engelmann B, Altenburger R, Rolle-Kampczyk U, Grintzalis K 2023b: Molecular responses of daphnids to chronic exposures to pharmaceuticals. Int J Mol Sci 24: 4100
<https://doi.org/10.3390/ijms24044100>
51. KE, Ferris K, Griffith E, Sherman BL 2018: Use of single-dose oral gabapentin to attenuate fear responses in cage-trap confined community cats: a double-blind, placebo-controlled field trial. J Feline Med Surg 20: 535-543
<https://doi.org/10.1177/1098612X17719399>
52. SR, Adams V, Garosi L, Abramson CJ, Penderis J, De Stefani A, Matiasek L 2006: Treatment with gabapentin of 11 dogs with refractory idiopathic epilepsy. Vet Rec 159: 881-884
<https://doi.org/10.1136/vr.159.15.495>
53. J, Golovko O, Carlsson G, Eriksson J, Glynn A, Örn S et al. 2020: Carbamazepine ozonation byproducts: toxicity in zebrafish (Danio rerio) embryos and chemical stability. Environ Sci Technol 54: 2913-2921
<https://doi.org/10.1021/acs.est.9b07100>
54. Porter RJ, Dhir A, Macdonald RL, Rogawski MA 2012: Mechanisms of action of antiseizure drugs. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV (Eds): Epilepsy. Handbook of Clinical Neurology. Elsevier, Volume 108, pp. 663-681
55. Prakash C 2014: Gabapentin. In: Lee PW (Ed.): Handbook of Metabolic Pathways of Xenobiotics. Wiley, Chichester.
56. GC 2017: Review about gabapentin misuse, interactions, contraindications and side effects. J Exp Pharmacol 9: 13-21
<https://doi.org/10.2147/JEP.S124391>
57. J, Yoom H, Son H, Lee Y 2020: Occurrence and transformation of gabapentin in urban water quality engineering: Rapid formation of nitrile from amine during drinking water chlorination. Water Res 184: 116123
<https://doi.org/10.1016/j.watres.2020.116123>
58. LL, Türck D, von Hodenberg A, Vollmer KO, McNally WP, DeHart PD, Hanson BJ, Bockbrader HN, Chang T 1995: Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys. Drug Metab Dispos 23: 441-448
<https://doi.org/10.1016/S0090-9556(25)06578-X>
59. R, Olaitan O, McCobb E 2021: Evaluation of prescribing practices for gabapentin as an analgesic among veterinary professionals. Vet Anaesth Analg 48: 775-781
<https://doi.org/10.1016/j.vaa.2021.06.007>
60. MA, Porter RJ 1990: Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol Rev 42: 223-286
<https://doi.org/10.1016/S0031-6997(25)00046-8>
61. HLM, Watanabe R, Evangelista MC, Beauchamp G, Auger JP, Segura M, Steagall PV 2020: Pain burden, sensory profile and inflammatory cytokines of dogs with naturally-occurring neuropathic pain treated with gabapentin alone or with meloxicam. PLoS One 15: e0237121
<https://doi.org/10.1371/journal.pone.0237121>
62. A, Meuthen D, Attaran A, Chivers DP, Ferrari MCO 2023: Effects of common antiepileptic drugs on teleost fishes. Sci Total Environ 866: 161324
<https://doi.org/10.1016/j.scitotenv.2022.161324>
63. JW 2004: The use of antiepileptic drugs—principles and practice. Epilepsia 45: 28-34
<https://doi.org/10.1111/j.0013-9580.2004.455005.x>
64. B 2007: Clinical development of antiepileptic drugs in adults. Neurotherapeutics 4: 62-69
<https://doi.org/10.1016/j.nurt.2006.11.013>
65. G 2006: The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol 6: 108-113
<https://doi.org/10.1016/j.coph.2005.11.003>
66. B 2012: Anticonvulsants: aspects of their mechanisms of action. Eur J Pain 6: 3-9
<https://doi.org/10.1053/eujp.2001.0315>
67. Somerville ER, Michell AW, Sen A 2015: Gabapentin. In: Shorvon S, Perucca E, Engel J (Eds): The Treatment of Epilepsy. 4th edition. Wiley, pp. 479-488
68. EK 2009: Minimizing AED adverse effects: improving quality of life in the interictal state in epilepsy care. Curr Neuropharmacol 7: 106-114
<https://doi.org/10.2174/157015909788848857>
69. KA, Forsythe LRE, Stelow EA, Bain MJ 2017: Effects of a single preappointment dose of gabapentin on signs of stress in cats during transportation and veterinary examination. J Am Vet Med Assoc 251: 1175-1181
<https://doi.org/10.2460/javma.251.10.1175>
70. J, Massie A, Portelli J, Di Giovanni G, Smolders I 2013: Are vesicular neurotransmitter transporters potential treatment targets for temporal lobe epilepsy? Front Cell Neurosci 7: 1-10
<https://doi.org/10.3389/fncel.2013.00139>
71. KO, von Hodenberg A, Kölle EU 1986: Pharmacokinetics and metabolism of gabapentin in rat, dog and man. Arzneimittelforschung 36: 830-839
72. J, Dvořáková Březinová T, Koželuh M, Kule L 2017: Occurrence and removal of pharmaceuticals in four full-scale constructed wetlands in the Czech Republic – the first year of monitoring. Ecol Eng 98: 354-364
<https://doi.org/10.1016/j.ecoleng.2016.08.010>
73. HS 1999: Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. Epilepsia 40: S2-S10
<https://doi.org/10.1111/j.1528-1157.1999.tb00913.x>
74. World Health Organization 2022: Executive Summary. 51st Meeting of the WHO International Working Group for Drug Statistics Methodology, March 24–25, 2022. Available at: https://cdn.who.int/media/docs/default-source/international-nonproprietary-names-(inn)/atc-ddd/51st_atc_ddd_executive_summary.pdf. Accessed January 7, 2025
75. World Health Organization Collaborating Centre for Drug Statistics Methodology 2023: ATC/DDD. Available at: https://www.whocc.no/atc_ddd_index/. Accessed January 23, 2025
76. JH, Ferrer I, Barber LB, Thurman EM 2013: Widespread occurrence of neuro-active pharmaceuticals and metabolites in 24 Minnesota rivers and wastewaters. Sci Total Environ 461-462: 519-527
<https://doi.org/10.1016/j.scitotenv.2013.04.099>
77. Yasaei R, Katta S, Saadabadi A 2024: Gabapentin. In: StatPearls. StatPearls Publishing, Treasure Island (FL). Available at: https://www.ncbi.nlm.nih.gov/books/NBK493228/. Accessed March 5, 2025
